BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Pfizer Inc. (PFE), Novartis AG (NVS) Circle Strides Arcolab Limited Unit


8/17/2012 7:42:59 AM

Global drug-makers including Novartis and Pfizer are among 'serious bidders' considering bidding for Bangalore-based Strides Arcolabs injectable-drugs unit, Agila Specialties, two people aware of the matter said. US-based buyout fund Kohlberg Kravis Roberts & Co. is also considering a bid for Agila Specialties, according to one of the people quoted above. Strides Arcolab is seeking between $1.6-2 billion for the sale of Agila Specialties, more than two times the company's market value. The unit accounts for nearly half the company's gross profits. Strides is likely to initiate a formal auction process for the sale of the unit by end of September.

Read at India Times
Read at Bloomberg
Read at News Release

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->